Form 4 for DXCM Dexcom
Accepted 2024-03-26 00:00:00 ET · period of report 2024-03-25 · accession 0001093557-24-000058 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-26 | 2024-03-25 | DXCM | Stern Sadie | EVP Chief Human Resources | S - Sale | $140.00 | -4,137 | 76.3K | -5% | -$579.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-25 | S | D | 4,137 | $140.00 | 76,304 | D | — | — | (F1) On December 15, 2022, Ms. Stern adopted a 10b5-1 Plan which was amended on December 12, 2023. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Stern. The shares set forth above were sold pursuant to the 10b5-1 Plan. (F2) Included in this number are 53,995 unvested restricted stock units, 21,711 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 14,512 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 7,060 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,504 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 8,208 of which were granted on November 19, 2020 and shall vest through November 19, 2024. |